Nurix Therapeutics, Inc.: RBC cuts target price to $35 from $36
NRIX•RBC cut its target price for Nurix Therapeutics to $35 from $36.
Related News
Nurix Therapeutics: Truist Securities cuts target price to $33 from $34
NRIX•
SKK Holdings completes $258.8 million acquisition of drone assets from Rantizo
SKK•
Trump defends Russia diesel deal as lawmakers from both parties complain
USO•
Huntsman Corp: RBC cuts target price to $9 from $10
HUN•
Europe gets the yuan rise it wants — just not the way it wanted
FXI•